These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14579947)

  • 1. Acute renal failure after administration of a single dose of a highly selective COX-2 inhibitor.
    Reinhold SW; Fischereder M; Riegger GA; Krämer BK
    Clin Nephrol; 2003 Oct; 60(4):295-6. PubMed ID: 14579947
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib.
    Rocha JL; Fernández-Alonso J
    Lancet; 2001 Jun; 357(9272):1946-7. PubMed ID: 11425419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute, anuric renal failure associated with two doses of a cyclooxygenase-2 inhibitor.
    Wahba AL; Soper C
    Nephron; 2001 Oct; 89(2):239. PubMed ID: 11549912
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin lactic acidosis, acute renal failure and rofecoxib.
    Price G
    Br J Anaesth; 2003 Dec; 91(6):909-10. PubMed ID: 14633764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy with rofecoxib. Decreasing risk by controlled COX-2 inhibitor administration].
    MMW Fortschr Med; 2000 Nov; 142(48):64-5. PubMed ID: 11144940
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute onset of neutrophilic dermatosis in patients after therapy with a COX-2-specific inhibitor.
    Smith KJ; Skelton H
    Int J Dermatol; 2003 May; 42(5):389-93. PubMed ID: 12755981
    [No Abstract]   [Full Text] [Related]  

  • 7. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
    Einecke D
    MMW Fortschr Med; 2002 Nov; 144(46):68. PubMed ID: 12534087
    [No Abstract]   [Full Text] [Related]  

  • 8. Arthritis. Should you be taking a COX-2 inhibitor?
    Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
    [No Abstract]   [Full Text] [Related]  

  • 9. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H
    MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analgesic in osteoporosis. Why so conservative with dosage?].
    Pfeifer M
    MMW Fortschr Med; 2002 Sep; 144(35-36):9. PubMed ID: 12380349
    [No Abstract]   [Full Text] [Related]  

  • 11. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
    Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephrotoxicity of selective COX-2 inhibitors.
    Woywodt A; Schwarz A; Mengel M; Haller H; Zeidler H; Köhler L
    J Rheumatol; 2001 Sep; 28(9):2133-5. PubMed ID: 11550988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is concern about cardiovascular events with the new coxib class of drugs justified?
    Schnitzer TJ
    Medscape Womens Health; 2001 Oct; 6(5):8. PubMed ID: 11698930
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stomach-saving "Coxibs". No reason for therapeutic risks].
    MMW Fortschr Med; 2001 Jan; 143(3):56. PubMed ID: 11215349
    [No Abstract]   [Full Text] [Related]  

  • 15. [Elderly patient with rheumatoid arthritis. Minimizing the peptic ulcer hemorrhage risk].
    MMW Fortschr Med; 2001 Aug; 143(31-32):46. PubMed ID: 11556192
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prof. Bernd Simon on nonsteroidal anti-inflammatory drugs. Gastrointestinal complications are unpredictable].
    Simon B
    MMW Fortschr Med; 2001 May; 143(18):51-2. PubMed ID: 11387712
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular risk: a class effect of coxibs? How to manage patients taking Vioxx?].
    Brune K; Zacher J
    MMW Fortschr Med; 2004 Oct; 146(42):10, 12. PubMed ID: 15536697
    [No Abstract]   [Full Text] [Related]  

  • 18. Rofecoxib does not adversely affect skin graft survival in a rat model.
    Miller Q; Losken A; Harre JG; Bird ME
    Curr Surg; 2004; 61(2):227-30. PubMed ID: 15051270
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rofecoxib, a new NSAID preparation with selective COX-2 inhibition].
    Pødenphant J
    Ugeskr Laeger; 2000 Sep; 162(39):5233-6. PubMed ID: 11043057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Slime fight in the lay media. Were the Vioxx fatal cases kept secret?].
    Zierenberg O
    MMW Fortschr Med; 2004 Oct; 146(43):60. PubMed ID: 15559526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.